Ultima-CJC no DAC 5mg

MANUFACTURER
Ultima Pharmaceuticals - US
WAREHOUSE
USA Warehouse 5
SUBSTANCE
GHRH Peptide

Your order will arrive discreetly, as products are shipped without branding for your security.

CJC-1295 is a powerful synthetic analogue of growth hormone-releasing hormone (GHRH), composed of 30 amino acids. Renowned for its ability to enhance growth hormone and IGF-1 secretion, CJC-1295 maintains the natural rhythm of GH release, making it a favorite among fitness enthusiasts and health aficionados alike.

This remarkable peptide is often combined with Ipamorelin to boost its specificity as a GHRH. While it effectively elevates growth hormone levels, it does so without increasing appetite or causing spikes in cortisol, acetylcholine, prolactin, or aldosterone, unlike many other peptides. CJC-1295 is well-tolerated and synergizes perfectly with Ipamorelin.

Target Gland: Pituitary

Key Benefits of CJC-1295:

• Enhanced secretion of growth hormone and IGF-1 without raising prolactin levels
• Increased body weight and height through improved protein synthesis
• Significant muscle mass development
• Higher bone density for stronger skeletal health
• Boosted immune response for overall well-being
• Enhanced cognitive function and memory retention
• Increased collagen synthesis for youthful skin
• Greater fat loss for a lean physique
• Improved cellular repair and regeneration

Moreover, CJC-1295 supports deep, restful sleep, essential for muscle recovery and cognitive function.

There are two variants of CJC-1295:

The first, GHRH, is produced in the hypothalamus and releases growth hormone in a pulsatile manner from the pituitary but has a very short half-life of just a few minutes. The active segment of GHRH, made up of the first 29 amino acids, is available as a manufactured peptide called Sermorelin. This was modified to extend its half-life to approximately 30 minutes, leading to the creation of CJC-1295. Further enhancements include the addition of DAC (Drug Affinity Complex), which binds to the protein albumin, extending its half-life to around 8 days, known as CJC-1295 + DAC. A non-DAC version is also available, creating a more natural growth hormone spike each night.

The longer half-life allows for just one or two injections per week, providing sustained stimulation for growth hormone release from the pituitary through the GHRH receptor, albeit this may reduce the amplitude of GH pulses and lead to decreased stimulation of GH-target tissues.

Safety Considerations:

To ensure optimal results, it's recommended to take 'hormone holidays' every three to six months while using long-acting forms of CJC. This allows the pituitary to recover, during which Sermorelin can serve as a substitute. These breaks may also help mitigate the risk of GH resistance, which can arise from antibodies that deactivate GH or a decrease in GH receptors on tissues (down-regulation). While these risks are theoretical, no long-term studies have definitively confirmed them.

Potential Side Effects: Users may experience mild side effects such as injection site reactions (irritation, redness, swelling, pain, itching), headaches, diarrhea, flushing, transient low blood pressure, nausea, and abdominal discomfort.